Investor Ideas #Potcasts #Cannabis
News and Stocks on the Move: TSX: $ACB.TO, TSX: $WEED.TO, NYSE: $CGC, CSE:
$CRZ.C, CSE: $PVOT.C, TSXV: $GENE.V
August 7th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Delta, Kelowna, BC –August 7, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/08071Potcasts-TSX-ACB-WEED-NYSE-CGC-CSE-CRZ-PVOT-GENE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news announcements from Liberty Health Sciences
Inc. trading on the CSE as LHS, Aurora Cannabis Inc. trading on the TSX as ACB
and the OTCQB as ACBFF, Canopy Growth Corporation trading on the TSX as WEED
and the NYSE as CGC, CannaRoyalty Corp.
trading on the CSE as CRZ, Pivot Pharmaceuticals Inc. trading on the CSE
as PVOT and the OTCQB as PVOTF and
INVICTUS MD STRATEGIES CORP. trading on the TSX-Venture as GENE.
Liberty Health Sciences Inc., a provider of high quality pharmaceutical
grade cannabis, announced today that it has doubled its cultivation space in
Florida with production commencing at its Liberty Health Sciences 360
Innovation Campus in Gainesville in response to the growing demand by Florida
patients. The Company received permission to commence production at the 360
Campus while a retrofit of the facilities is being completed. The Company's
Chestnut Hill facility continues to operate at full capacity.
The Company also announced that it has five more leases in place for
Cannabis Education Centers including: Boca Raton,
Gainesville, Winterhaven, Palm Harbor and Sarasota.
In accordance with the Company's rapidly expanding presence in Florida,
production of Liberty's newest and highly anticipated offering to consumers,
Mary's Medicinals, has commenced production. The entire award-winning line
of innovative Mary's products will soon be available in all of Liberty's
Cannabis Education Centers (CEC). Products will include: transdermal patches,
transdermal gel pens, topicals, capsules, tinctures and vape pens.
Aurora Cannabis Inc. announced today that it has entered into a letter
of intent whereby Aurora intends to acquire the cannabis business of HotHouse
Consulting Inc., a provider of advanced greenhouse consulting services.
Founded by industry veteran Laust Dam in 2004, HotHouse specializes in
hybrid greenhouse growing techniques. Since its founding, HotHouse has
consulted on a variety of agricultural crops but has focused in recent years on
the specialized requirements of large scale cannabis production. With more than
70 years of combined experience, HotHouse's team of consultants currently
provide services for approximately 50 customers globally. Upon closing of the
acquisition, Laust Dam will join Aurora Larssen Projects ("ALPS") as
VP of Horticultural Development.
Canopy Growth Corporation announced that it has completed the previously
announced acquisition of Canopy Health Innovations Inc. ("CHI"),
including the subsidiary operations of Canopy Animal Health Inc.
("CAH"). The Company believes its strategy of integrating and
aligning CHI's clinical platform with the international work of Spectrum
Cannabis, will accelerate its comprehensive research programs, build evidence
around Canopy products and formulations and ultimately improve patient
access to medical cannabis globally.
CHI has built a diversified business focused on unlocking the
therapeutic and commercial potential of cannabis for both humans and animals.
Incorporating CHI into this ecosystem as a wholly-owned subsidiary will
increase efficiencies and unlock the full potential of CHI's significant IP
portfolio including 39 patent applications filed with the United States Patent
Trade Office.
CannaRoyalty Corp., a leading North American
cannabis products and brands company, today announced that it plans to release
its financial results for the second quarter ended June 30, 2018 on Thursday,
August 23, 2018 at 6:30 a.m. ET.
The Company will host a conference call on Thursday, August 23, 2018 at
8:30 a.m. ET to discuss financial results and provide investors with key
business highlights. The call will be chaired by Marc Lustig, Chairman and
Chief Executive Officer, François Perrault, Chief Financial Officer and Afzal
Hasan, President and General Counsel.
Pivot Pharmaceuticals Inc. announced that it has signed a Definitive
Agreement with Israeli-based SoluBest Ltd. to acquire the worldwide rights for
the use, development and commercialization of its patented Solumer™ Oral Drug
Delivery Technology ("Solumer™") for the improved bioavailability,
delivery and commercialization of Cannabidiol (CBD), Tetrahydrocannabinol (THC)
and other biocannabis-based products.
A patented and versatile technology, Solumer™ was developed by SoluBest
Ltd. to maximize the solubility, bioavailability and physical stability of drug
substances utilizing submicron particle engineering. SoluBest then achieves
clear powder formulations through a spray drying process. Submicron technology
has been proven in pre-clinical trials to significantly enhance bioavailability,
and therefore drug performance. Dissolution profiles in intestinal media
demonstrate a high dissolution rate and saturation solubility resulting in
improved drug absorption, at a rate 10-15 times greater than control.
In 2016, cannabinoid edibles accounted for approximately 16% of U.S.
sales of cannabis products.1 Furthermore, Cannabiz Consumer Group
states that cannabis-infused beverages could represent a $15 billion market
opportunity upon legalization.
INVICTUS MD STRATEGIES CORP. announced that its wholly
owned subsidiary, Acreage Pharms Ltd., has received an amended license from
Health Canada, under the Access to Cannabis for Medical Purposes Regulations
("ACMPR"), to include
the production of bottled cannabis oil and cannabis resin, effective August 3,
2018.
Acreage Pharms' state-of-the-art closed-loop CO2 extraction
process produces the highest-quality cannabis oils in the world. The system
performs Subcritical and Supercritical Fluid Extraction utilizing high-pressure
carbon dioxide to extract essential oils from botanicals, using specific
temperatures and pressures to withdraw different components from plants.
Through this extraction process, CBD and THC levels can be adjusted to ensure a
diverse selection for consumers.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Potcasts is now a certified word mark Trademark on the blockchain through
Cognate, Inc. CM Certification
Investorideas.com podcasts are also available on iTunes, Spotify,
Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.
If you would like to be a guest or sponsor this podcast contact
Investorideas.com
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, iHeartradio and
Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info
http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
